Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Assets: 2017-2024

Historic Return on Assets for Akebia Therapeutics (AKBA) over the last 8 years, with Dec 2024 value amounting to -0.30%.

  • Akebia Therapeutics' Return on Assets rose 17.00% to -0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.04%, marking a year-over-year increase of 17.00%. This contributed to the annual value of -0.30% for FY2024, which is 13.00% down from last year.
  • As of FY2024, Akebia Therapeutics' Return on Assets stood at -0.30%, which was down 72.81% from -0.17% recorded in FY2023.
  • Akebia Therapeutics' Return on Assets' 5-year high stood at -0.17% during FY2023, with a 5-year trough of -0.54% in FY2020.
  • For the 3-year period, Akebia Therapeutics' Return on Assets averaged around -0.23%, with its median value being -0.21% (2022).
  • Its Return on Assets has fluctuated over the past 5 years, first dropped by 23bps in 2020, then climbed by 27bps in 2022.
  • Yearly analysis of 5 years shows Akebia Therapeutics' Return on Assets stood at -0.54% in 2020, then rose by 6bps to -0.48% in 2021, then rose by 27bps to -0.21% in 2022, then grew by 4bps to -0.17% in 2023, then fell by 13bps to -0.30% in 2024.